Claims
- 1. A membrane and needle assembly for testing constituents of body fluid while avoiding contamination of testing from undesirable elements of the fluid, the assembly comprising:
- a membrane for receiving a body fluid to be tested, the membrane having a generally planar test area, the membrane further including a transfer area spaced from the test area and in fluid communication with the test area;
- a needle having a penetration end for penetration into a skin layer of a patient, the needle having a discharge end, the discharge end defining an opening; and
- the needle disposed relative to the transfer area and fixed relative thereto and with the opening of the discharge end being substantially parallel to and in fixed close proximity to the transfer area wherein fluid flowing through the opening flows along a line of travel generally perpendicular to the transfer area.
- 2. An assembly according to claim 1 further comprising a light source in optical communication with the test area.
- 3. An assembly according to claim 1 wherein the transfer area is substantially orthogonal to the test area.
- 4. An assembly according to claim 1 wherein the membrane includes a filter area disposed between the transfer area and the test area, and a filtering substance contained within the filter area for removing the undesirable elements from the transfer area and through the filter area to the test area.
- 5. An assembly according to claim 4 wherein the undesirable elements includes blood cells and the filtering substance includes means for preventing proteins passing through the filter area.
- 6. An assembly according to claim 5 wherein the means is a deposited amount of a binding agent within the filter area for adherence of proteins to the agent.
- 7. An assembly according to claim 6 wherein the proteins are portions of blood cells.
- 8. An assembly according to claim 5 wherein the undesirable elements are cell fragments.
CROSS-REFERENCE TO RELATED APPLICATION
The present application discloses, in part, subject matter disclosed in commonly assigned and copending U.S. application Ser. No. 08/708,923, filed Sep. 6, 1996, now issued as U.S. Pat. No. 5,823,973; U.S. patent application Ser. No. 08/525,390 now abandoned, entitled "Interstitial Fluid Sampler" filed Sep. 8, 1995 in the name of Paul D. Brinda; and of U.S. patent application Ser. No. 08/525,942 now abandoned entitled "Enhanced Interstitial Fluid Collection" and filed Sep. 8, 1995 in the name of inventors Scott T. Latterell, Paul D. Brinda, Michael E. Hilgers, Michael J. Shoup, Thomas B. Hoegh and Brian J. Erickson. The present application also discloses subject matter disclosed in commonly assigned U.S. patent application Ser. No. 08/706,663, now U.S. Pat. No. 5,879,310, issued on Mar. 9, 1999, entitled "Body Fluid Sampler" and filed concurrently herewith in the names of inventors John P. Sopp, Scott T. Latterell, Paul D. Brinda, and Timothy J. Erskine.
US Referenced Citations (17)
Foreign Referenced Citations (2)
Number |
Date |
Country |
405095938 |
Apr 1993 |
JPX |
WO 9118548 |
Dec 1991 |
WOX |